Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 81, Issue 1
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Recommendation
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
Free
Online download statistics by month:
Online download statistics by month: October 2021 to June 2022
Abstract
Full
Pdf
Oct 2021
1846
1816
993
Nov 2021
1105
1091
316
Dec 2021
1000
1005
348
Jan 2022
1691
1687
720
Feb 2022
833
832
356
Mar 2022
576
583
275
Apr 2022
447
448
215
May 2022
340
345
175
Jun 2022
331
336
173
Total
8169
8143
3571
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF